Literature DB >> 11920553

Cytoplasmic expression of laminin gamma2 chain correlates with postoperative hepatic metastasis and poor prognosis in patients with pancreatic ductal adenocarcinoma.

Shinichiro Takahashi1, Takahiro Hasebe, Tatsuya Oda, Satoshi Sasaki, Taira Kinoshita, Masaru Konishi, Takenori Ochiai, Atsushi Ochiai.   

Abstract

BACKGROUND: The laminin gamma2 chain is involved in tumor invasion and metastasis, but the significance of laminin gamma2 chain expression remains unclear in patients with pancreatic carcinoma.
METHODS: Laminin gamma2 chain expression was examined immunohistochemically in 48 patients with pancreatic ductal adenocarcinoma who were followed closely to elucidate the correlations between clinicopathologic factors, postoperative recurrence, and overall survival. Prognostic factors for postoperative survival were examined comparing clinicopathologic factors and laminin gamma2 chain expression.
RESULTS: Two different staining patterns of laminin gamma2 chain expression, cytoplasmic expression and basement membrane expression, were detected in tumors from all 48 patients. Tumors were then classified into two types according to the dominant pattern of laminin gamma2 chain expression: the cytoplasmic expression dominant type (CYT; n = 26 patients) and the basement membrane expression dominant type (BM; n = 22 patients). Tumor differentiation was associated statistically with the BM type of laminin gamma2 chain expression (P = 0.0002). The CYT type of laminin gamma2 chain expression was associated significantly with the occurrence of postoperative hepatic metastasis (P = 0.0011) and also was the strongest predictive factor for poorer overall survival in patients with pancreatic ductal adenocarcinomas (P = 0.0161).
CONCLUSIONS: The cytoplasmic expression of the laminin gamma2 chain represents the high invasive potential of the tumor and is correlated with distant metastasis, especially hepatic metastasis, and with a poorer prognosis in patients with pancreatic ductal adenocarcinoma. Copyright 2002 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11920553     DOI: 10.1002/cncr.10395

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  29 in total

1.  Analysis of liver metastasis after resection for pancreatic ductal adenocarcinoma.

Authors:  Kwang Yeol Paik; Seong Ho Choi; Jin Seok Heo; Dong Wook Choi
Journal:  World J Gastrointest Oncol       Date:  2012-05-15

2.  Laminin-5γ-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration, and invasion by modulating signaling of EGFR.

Authors:  Manoj Garg; Deepika Kanojia; Ryoko Okamoto; Saket Jain; Vikas Madan; Wenwen Chien; Abhishek Sampath; Ling-Wen Ding; Meng Xuan; Jonathan W Said; Ngan B Doan; Li-Zhen Liu; Henry Yang; Sigal Gery; Glenn D Braunstein; H Phillip Koeffler
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

3.  LAMC2 enhances the metastatic potential of lung adenocarcinoma.

Authors:  Y W Moon; G Rao; J J Kim; H-S Shim; K-S Park; S S An; B Kim; P S Steeg; S Sarfaraz; L Changwoo Lee; Donna Voeller; E Y Choi; Ji Luo; D Palmieri; H C Chung; J-H Kim; Y Wang; G Giaccone
Journal:  Cell Death Differ       Date:  2015-01-16       Impact factor: 15.828

4.  Clinicopathological significance of MMP-7, laminin γ2 and EGFR expression at the invasive front of gastric carcinoma.

Authors:  Kazuhiro Sentani; Miho Matsuda; Naohide Oue; Naohiro Uraoka; Yutaka Naito; Naoya Sakamoto; Wataru Yasui
Journal:  Gastric Cancer       Date:  2013-09-19       Impact factor: 7.370

Review 5.  Laminin-5 in epithelial tumour invasion.

Authors:  Masahiko Katayama; Kiyotoshi Sekiguchi
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

Review 6.  Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-17       Impact factor: 4.553

7.  Cdk4/6 inhibition induces epithelial-mesenchymal transition and enhances invasiveness in pancreatic cancer cells.

Authors:  Fang Liu; Murray Korc
Journal:  Mol Cancer Ther       Date:  2012-08-06       Impact factor: 6.261

Review 8.  Defining the role of laminin-332 in carcinoma.

Authors:  Cherise M Guess; Vito Quaranta
Journal:  Matrix Biol       Date:  2009-08-15       Impact factor: 11.583

Review 9.  Microarray-based gene expression profiling in pancreatic ductal carcinoma: status quo and perspectives.

Authors:  Robert Grützmann; Hans Detlev Saeger; Jutta Lüttges; Hans Konrad Schackert; Holger Kalthoff; Günter Klöppel; Christian Pilarsky
Journal:  Int J Colorectal Dis       Date:  2004-01-24       Impact factor: 2.571

10.  Data perturbation independent diagnosis and validation of breast cancer subtypes using clustering and patterns.

Authors:  G Alexe; G S Dalgin; R Ramaswamy; C Delisi; G Bhanot
Journal:  Cancer Inform       Date:  2007-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.